Objective To summarize the research in tissue regeneration and engineered scaffold materials for the prevention and treatment of lymphedema. Methods The recent domestic and international literature about lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials for the prevention and treatment of lymphedema was extensively reviewed and summarized, and the progress of tissue engineered scaffold materials in prevention and treatment of lymphedema was emphatically introduced. Results Lymphangiogenesis-related factors, stem cells, and tissue engineered scaffold materials utilize two main strategies to prevent and treat lymphedema: promoting lymphatic network regeneration in vivo and constructing functional lymphatic tissues for transplantation in vitro. Conclusion Tissue regeneration and engineered scaffold materials provide new approaches for the prevention and treatment of lymphedema. Although innovative developments have been made, most are still at the basic research stage, and clinical translation remains a challenge.
Citation：
YUAN Shaoxiang, DENG Chengliang. Research on tissue regeneration and engineered scaffold materials in prevention and treatment of lymphedema. Chinese Journal of Reparative and Reconstructive Surgery, 2026, 40(3): 511-518. doi: 10.7507/1002-1892.202509027
Copy
Copyright ? the editorial department of Chinese Journal of Reparative and Reconstructive Surgery of West China Medical Publisher. All rights reserved
| 1. |
|
| 2. |
|
| 3. |
|
| 4. |
|
| 5. |
|
| 6. |
|
| 7. |
|
| 8. |
|
| 9. |
|
| 10. |
|
| 11. |
|
| 12. |
|
| 13. |
|
| 14. |
|
| 15. |
|
| 16. |
|
| 17. |
|
| 18. |
|
| 19. |
|
| 20. |
|
| 21. |
|
| 22. |
|
| 23. |
|
| 24. |
|
| 25. |
|
| 26. |
|
| 27. |
|
| 28. |
|
| 29. |
|
| 30. |
|
| 31. |
|
| 32. |
|
| 33. |
|
| 34. |
|
| 35. |
|
| 36. |
|
| 37. |
|
| 38. |
|
| 39. |
|
| 40. |
|
| 41. |
|
| 42. |
|
| 43. |
|
| 44. |
|
| 45. |
|
| 46. |
|
| 47. |
|
| 48. |
|
| 49. |
|
| 50. |
|
| 51. |
Razavi MS, Lei PJ, Amoozgar Z, et al. Regeneration of collecting lymphatic vessels following injury. Res Sq, 2023. doi: 10.21203/rs.3.rs-3025656/v1.
|
| 52. |
|
| 53. |
Hadamitzky C, Zaitseva TS, Bazalova-Carter M, et al. Aligned nanofibrillar collagen scaffolds—Guiding lymphangiogenesis for treatment of acquired lymphedema. Biomaterials, 2016, 102: 259-267.
|
| 54. |
|
| 55. |
|
| 56. |
|
| 57. |
|
| 58. |
|
| 59. |
|
| 60. |
|
| 61. |
|
| 62. |
|
| 63. |
|
| 64. |
|
| 65. |
Hinderer S, Layland SL, Schenke-Layland K. ECM and ECM-like materials—Biomaterials for applications in regenerative medicine and cancer therapy. Adv Drug Deliv Rev, 2016, 97: 260-269.
|
| 66. |
|
| 67. |
|
| 68. |
|
| 69. |
|
| 70. |
|
| 71. |
|
| 72. |
|
| 73. |
|
| 74. |
|
| 75. |
|
| 76. |
Giese C, Demmler CD, Ammer R, et al. A human lymph node in vitro—challenges and progress. Artif Organs, 2006, 30(10): 803-808.
|
| 77. |
|
| 78. |
|
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
- 23.
- 24.
- 25.
- 26.
- 27.
- 28.
- 29.
- 30.
- 31.
- 32.
- 33.
- 34.
- 35.
- 36.
- 37.
- 38.
- 39.
- 40.
- 41.
- 42.
- 43.
- 44.
- 45.
- 46.
- 47.
- 48.
- 49.
- 50.
- 51. Razavi MS, Lei PJ, Amoozgar Z, et al. Regeneration of collecting lymphatic vessels following injury. Res Sq, 2023. doi: 10.21203/rs.3.rs-3025656/v1.
- 52.
- 53. Hadamitzky C, Zaitseva TS, Bazalova-Carter M, et al. Aligned nanofibrillar collagen scaffolds—Guiding lymphangiogenesis for treatment of acquired lymphedema. Biomaterials, 2016, 102: 259-267.
- 54.
- 55.
- 56.
- 57.
- 58.
- 59.
- 60.
- 61.
- 62.
- 63.
- 64.
- 65. Hinderer S, Layland SL, Schenke-Layland K. ECM and ECM-like materials—Biomaterials for applications in regenerative medicine and cancer therapy. Adv Drug Deliv Rev, 2016, 97: 260-269.
- 66.
- 67.
- 68.
- 69.
- 70.
- 71.
- 72.
- 73.
- 74.
- 75.
- 76. Giese C, Demmler CD, Ammer R, et al. A human lymph node in vitro—challenges and progress. Artif Organs, 2006, 30(10): 803-808.
- 77.
- 78.
